Complement Therapeutics raised €72M in a Series A round in Apr 2023. The company is based in Munich, Germany. Investors in the round: BioGeneration Ventures, Cambridge Innovation Capital, Forbion and 4 others. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €72M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
